DynPort Vaccine Company LLC
60 Thomas Johnson Drive
8 articles with DynPort Vaccine Company LLC
Altimmune Signs Teaming Agreement with DynPort Vaccine Company on U.S. Government Funding Efforts for its COVID-19 Vaccine Candidate, AdCOVID™
Altimmune, Inc. announced that it has entered into a teaming agreement with DynPort Vaccine Company, a General Dynamics Information Technology company, to coordinate U.S. Government funding efforts and, if successful, to provide program management, drug development activity integration, and regulatory support for AdCOVID, Altimmune’s single-dose intranasal COVID-19 vaccine candidate.
AIBioTech Receives Subcontract Award From DynPort Vaccine Company LLC, for Continued Development and FDA Approval of a Nerve Agent Prophylactic
CSC's DynPort Vaccine Company LLC Wins $32.3 Million NIAID Contract to Establish Phase 1 Clinical Trial
ImmuneRegen BioSciences, Inc. to Provide Adjuvant to DynPort Vaccine Company LLC for Development of an Inactivated Vaccine against Venezuelan Equine Encephalitis Virus